ID3 and cancer: In the context of cancer, the above data together suggested that ectopic expression of ID3 in macrophages with low ID3, high SIRPA and low anti-tumour activity, such as mouse BMDMs or hiPSC-Macs, may endow them with high anti-tumour activity.